Wednesday, March 23, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, said it grossed $2 million by selling about 18.18 million units, consisting of one common share and a warrant for one-half of a common share, at 11 cents per unit. Each warrant can be exercised within three years at a price of 16 cents.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.